A project to establish large-scale cell culture and manufacturing methods for regenerative medicine products, and to build commercial production, supply and sales capabilities by utilizing external contractors and the Company's own manufacturing sites. This includes preparing commercial manufacturing sites and considering sales models for HLCM051.